EBVALLO
ATA129-EBV-302
Phase 3 small_molecule active
Quick answer
EBVALLO for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease is a Phase 3 program (small_molecule) at Pierre Fabre Medicament with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pierre Fabre Medicament
- Indication
- Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active